Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

The integration of Oracle Argus enables QPS to better capture, manage, and report adverse events for regulatory requirements.

Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...

The trial achieved its primary endpoint, showing a statistically significant reduction in Valsalva LVOT gradient at week 28.

As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

Texas Oncology is now offering Texoma residents access to clinical trials for cancer treatment. Texas Oncology provides ...